Updated Jul 16, 2026 · Last SEC filing 2026-06-23
MYRIAD GENETICS INC (MYGN) has filed 15 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-23. 3 Form 8-K material event filings were reported by MYGN in the last 90 days. 1 Form 144 notices of proposed sale were filed for MYGN stock. InsiderAlpha tracks every MYGN SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0000899923 |
|---|
| Form 4 filings (90d) | 15 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 1 |
| Latest Form 4 filing | 2026-06-23 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Donnelly Brian J | Chief Commerical Officer | A — Grant or award | 5.0K | $3.94 | $20K | SEC | |
| Raha Samraat S. | President and CEO | A — Grant or award | 3.5K | $3.94 | $14K | SEC | |
| Kumar Rashmi | Director | S — Open-market sale | 15.0K | $4.46 | $67K | SEC | |
| Phanstiel S. Louise | Director | A — Grant or award | 59.7K | $0.00 | — | SEC | |
| Davis Mark Steven | Director | A — Grant or award | 59.7K | $0.00 | — | SEC | |
| Reitan Colleen F | Director | A — Grant or award | 59.7K | $0.00 | — | SEC | |
| Dreismann Heinrich | Director | A — Grant or award | 59.7K | $0.00 | — | SEC | |
| Skovronsky Daniel | Director | A — Grant or award | 59.7K | $0.00 | — | SEC | |
| Kumar Rashmi | Director | A — Grant or award | 59.7K | $0.00 | — | SEC | |
| Bisaro Paul | Director | A — Grant or award | 59.7K | $0.00 | — | SEC | |
| Newcomer Lee Nisley | Director | A — Grant or award | 59.7K | $0.00 | — | SEC | |
| Jampa Raj | Chief Technology Officer | A — Grant or award | 251.9K | $0.00 | — | SEC | |
| Bisaro Paul | Director | P — Open-market purchase | 7.5K | $3.69 | $28K | SEC | |
| Donnelly Brian J | Chief Commerical Officer | F — Tax withholding / forfeiture | 56.0K | $4.80 | $269K | SEC | |
| Muzzey Dale | Chief Scientific Officer | F — Tax withholding / forfeiture | 946 | $4.91 | $5K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for MYRIAD GENETICS INC (MYGN). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Kumar Rashmi | 2 | $67K |
| Skovronsky Daniel | 2 | — |
| Bisaro Paul | 2 | $28K |
| Donnelly Brian J | 2 | $288K |
| Davis Mark Steven | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in MYGN insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live MYGN dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.